Since COVID, pharma manufacturers have shifted from lean, centralized supply chains toward regionalized hubs — balancing cost, flexibility, and geopolitical security to build resilience against future economic shocks.
Chemical companies face rising volatility, weak demand and structural challenges. AI-powered reinvention can offer a path to faster growth, lower costs and greater competitiveness by transforming how work gets done.
Atomgrid is a specialty chemicals platform built on a simple bet: put customer access before manufacturing. The company is scaling a "downstream-first" agrochemicals business towards global category leadership.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International
The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.
17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.
November, 17– 18, 2026 | All you want to know about advanced recycling technologies and renewable chemicals, building-blocks, monomers, and polymers based on recycling.
The event brings together researchers and industry experts to discuss recent advances in homogeneous catalysis and applied chemistry through presentations, technical exchange, and networking opportunities.
April 19-21, 2027 | The Pharmaceutical Manufacturing & Packaging Congress is a closed-door B2B event that fosters networking, knowledge-sharing, and benchmarking of industry practices among pharmaceutical industry professionals.
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.
